HOVON 68 CLL HOVON 68 CLL Version: April 14, 2008

 
HOVON 68 CLL
Protocol amendments
Version: April 14, 2008


 



 

A randomized phase III study in previously untreated patients with biological highrisk

CLL: Fludarabine + cyclophosphamide (FC) versus FC + low-dose alemtuzumab

EudraCT nr.: 2005-000309-75 



 

Pełna wersja do pobrania w pliku PDF:
HO68 AM2 listofchanges 031008


© 2017 Polska Grupa Badawcza chłoniaków. All Rights Reserved.

Login Form

Our website is protected by DMC Firewall!